Almonertinib (mesylate)


CAS No. : 2134096-06-1

(Synonyms: HS-10296 (mesylate))

2134096-06-1
Price and Availability of CAS No. : 2134096-06-1
Size Price Stock
5mg $250 In-stock
10mg $400 In-stock
25mg $750 In-stock
50mg $1050 In-stock
100mg $1450 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-112823A
M.Wt: 621.75
Formula: C31H39N7O5S
Purity: >98 %
Solubility: DMSO : 31.25 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 2134096-06-1 :

Almonertinib (HS-10296) mesylate is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM). Almonertinib mesylate is used for the research of the non-small cell lung cancer[1][2]. In Vitro: HS-10296 mesylate is an orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity, which canbe used to treat NSCLC[2]. Additionaly, HS-10296 mesylate could also inhibit other EGFR sensitive mutations, including G719X, del19, L858R and L861Q[3].

Your information is safe with us.